1921
Volume 87, Issue 2
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

Abstract

Abstract.

The aim of this work was to investigate the potential usefulness of lysate, recombinant protein JL7, and peptides P013, R13, JL18, JL19, and P0β as serological markers for human Chagas disease. We analyzed 228 sera from Brazilian Chagas disease patients classified into four clinical groups and 108 from non-chagasic patients. We defined the diagnostic sensitivity, specificity, and Kappa index measured by enzyme-linked immunosorbent assay (ELISA). As previously described, the highest values of diagnostic parameters were achieved for lysate and JL7; peptide P013 showed high specificity but low sensitivity. The other peptides resulted in lower sensitivity and specificity in our ELISA than lysate and JL7 protein. Antibodies against JL7 protein were mainly detected in sera from patients with severe chagasic cardiomyopathy, compared with those from the indeterminate form, whereas peptides failed to discriminate between the clinical forms of the disease.

Loading

Article metrics loading...

/content/journals/10.4269/ajtmh.2012.11-0533
2012-08-01
2017-11-22
Loading full text...

Full text loading...

/deliver/fulltext/14761645/87/2/267.html?itemId=/content/journals/10.4269/ajtmh.2012.11-0533&mimeType=html&fmt=ahah

References

  1. PAHO-WHO, 2006. Estimación cuantitativa de la enfermedad de Chagas en las Américas. OPS/HDM/CD/425-06.
  2. World Health Organization, 2002. Control of Chagas disease: Second Report of the WHO Expert Committee. WHO Technical report series 905. Geneva: WHO.
  3. Muniz J, Freitas G, , 1944. Contribuição para o diagnóstico da doença de Chagas pelas reações de imunidade. II - Isolamento de polissacarídeos de Schizotrypanum cruzi e de outros tripanosomídeos, seu comportamento nas reações de precipitação, de fixação do complemento e de hipersensibilidade. Os “Tests” de floculação (sublimado e formol-gel). Rev Bras Biol 4: 421438.
  4. Cerisola JA, Rosenbaum MB, , 1958. Complement-fixation reaction in the diagnosis of Chagas' disease. Prensa Med Argent 45: 14541463.
  5. Alvarez M, Cerisola JA, Rohweder RW, , 1968. Test de inmunofluorescencia para el diagnóstico de la enfermedad de Chagas. Bol Chil Parasitol 23: 48.
  6. Cerisola JA, Fatala Chaben M, Lazzari JO, , 1962. Hemagglutination test for the diagnosis of Chagas's disease. Prensa Med Argent 49: 17611767.
  7. Vattuone NH, Yanovsky JF, , 1971. Trypanosoma cruzi: agglutination activity of enzyme-treated epimastigotes. Exp Parasitol 30: 349355.[Crossref]
  8. Voller A, Draper C, Bidwell DE, Bartlett A, , 1975. A microplate enzyme-linked immunosorbent assay (ELISA) for Chagas disease. Lancet 1: 426429.[Crossref]
  9. Cura EN, Ruiz AM, Velazquez E, Malagrino N, Orn A, Segura EL, , 1993. Estandarización de un kit de confirmación (FATALAKIT) para el inmunodiagnóstico de la infección por el Trypanosoma cruzi . Medicina (B Aires) 53: 82.
  10. Caballero Z, Sousa O, Marques W, Saez-Alquezar A, Umezawa S, , 2007. Evaluation of serological tests to identify Trypanosoma cruzi infection in humans and determinate cross-reactivity with Trypanosoma rangeli and Leishmania spp. Clin Vaccine Immunol 14: 10451049.[Crossref]
  11. Da Silveira JF, Umezawa ES, Luquetti AO, , 2001. Chagas disease: recombinant Trypanosoma cruzi antigens for serological diagnosis. Trends Parasitol 17: 286291.[Crossref]
  12. Silva ED, Pereira VR, Gomes JA, Lorena VM, Cançado JR, Ferreira AG, Krieger MA, Goldenberg S, Correa-Oliveira R, Gomes YM, , 2002. Use of the EIE-recombinant-Chagas-Biomanguinhos kit to monitor cure of human Chagas' disease. J Clin Lab Anal 16: 132136.[Crossref]
  13. Umezawa ES, Luquetti AO, Levitus G, Ponce C, Ponce E, Henriquez D, Revollo S, Espinoza B, Sousa O, Khan B, da Silveira JF, , 2004. Serodiagnosis of chronic and acute Chagas' disease with Trypanosoma cruzi recombinant proteins: results of a collaborative study in six Latin American countries. J Clin Microbiol 42: 449452.[Crossref]
  14. Chang CD, Cheng KY, Jiang LX, Salbilla VA, Haller AS, Yem AW, Bryant JD, Kirchhoff LV, Leiby DA, Schochetman G, Shah DO, , 2006. Evaluation of a prototype Trypanosoma cruzi antibody assay with recombinant antigens on a fully automated chemiluminescence analyzer for blood donor screening. Transfusion 46: 17371744.[Crossref]
  15. Cooley G, Etheridge RD, Boehlke C, Bundy B, Weatherly DB, Minning T, Haney M, Postan M, Laucella S, Tarleton RL, , 2008. High throughput selection of effective serodiagnostics for Trypanosoma cruzi infection. PLOS Neg Trop Dis 2: 112.[Crossref]
  16. Luquetti AO, Ponce C, Ponce E, Esfandiari J, Schijman A, Revollo S, Anez N, Zingales B, Rangel-Aldao R, Gonzalez A, Levin MJ, Umezawa ES, Franco da Silveira J, , 2003. Chagas' disease diagnosis: a multicentre evaluation of Chagas Stat-Pack, a rapid immunochromatographic assay with recombinant proteins of Trypanosoma cruzi . Diagn Microbiol Infect Dis 46: 265271.[Crossref]
  17. Ponce C, Ponce E, Vinelli E, Montoya A, de Aguilar V, Gonzalez A, Zingales B, Rangel-Aldao R, Levin MJ, Estfandiari J, Umezawa ES, Luquetti AO, da Silveira JF, , 2005. Validation of a rapid and reliable test for diagnosis of Chagas' disease by detection of Trypanosoma cruzi-specific antibodies in blood of donors and patients in Central America. J Clin Microbiol 43: 50655068.[Crossref]
  18. Sosa-Estani S, Gamboa-León MR, Del Cid-Lemus J, Althabe F, Alger J, Almendares O, Cafferata ML, Chippaux JP, Dumonteil E, Gibbons L, Padilla-Raygoza N, Schneider D, Belizan JM, Buekens P, Working Group, , 2008. Use of a rapid test on umbilical cord blood to screen for Trypanosoma cruzi infection in pregnant women in Argentina, Bolivia, Honduras and Mexico. Am J Trop Med Hyg 79: 755759.
  19. World Health Organization, Report of the Scientific Working Group on Chagas Disease. Buenos Aires, Argentina, 17–20 April 2005. Geneva: World Health Organization. Available at: http://apps.who.int/tdr/publications/tdr-research-publications/reporte-enfermedad-chagas/pdf/swg_chagas.pdf.
  20. Levin MJ, Franco da Silveira J, Frasch AC, Camargo ME, Lafon S, Degrave WM, Rangel-Aldao R, , 1991. Recombinant Trypanosoma cruzi antigens and Chagas' disease diagnosis: analysis of a workshop. FEMS Microbiol Immunol 89: 1120.[Crossref]
  21. Umezawa ES, Bastos SF, Camargo ME, Yamaguchi LM, Santos MR, Gonzalez A, Zingales B, Levin MJ, Sousa O, Rangel-Aldao R, Franco da Silveira J, , 1999. Evaluation of recombinant antigens for serodiagnosis of Chagas' disease in South and Central America. J Clin Microbiol 37: 15541560.
  22. Gomes YM, Lorena VM, Luquetti AO, , 2009. Diagnosis of Chagas disease: what has been achieved? What remains to be done with regard to diagnosis and follow up studies? Mem Inst Oswaldo Cruz 104 (Suppl I): 115121.[Crossref]
  23. Foti L, Fonseca B de P, Nascimento LD, Marques C de F, da Silva ED, Duarte CA, Probst CM, Goldenberg S, Pinto AG, Krieger MA, , 2009. Viability study of a multiplex diagnostic platform for Chagas disease. Mem Inst Oswaldo Cruz 104 (1 Suppl): 136141.[Crossref]
  24. Levin MJ, Mesri E, Benarous R, Levitus G, Schijman A, Levy-Yeyati P, Chiale PA, Ruiz AM, Kahn A, Rosembaum MB, Torres HN, Segura EL, , 1989. Identification of major Trypanosoma cruzi antigenic determinants in Chronic Chagas's Heart Disease. Am J Trop Med Hyg 41: 530538.
  25. Tanowitz HB, Huang H, Jelicks LA, Chandra M, Loredo ML, Weiss LM, Factor SM, Shtutin V, Mukherjee S, Kitsis RN, Christ GJ, Wittner M, Shirani J, Kisanuki YY, Yanagisawa M, , 2005. Role of endothelin 1 in the pathogenesis of chronic chagasic heart disease. Infect Immun 73: 24962503.[Crossref]
  26. Talvani A, Rocha MO, Barcelos LS, Gomes YM, Ribeiro AL, Teixeira MM, , 2004. Elevated concentrations of CCL2 and tumor necrosis factor-α in chagasic cardiomyopathy. Clin Infect Dis 38: 943950.[Crossref]
  27. Wang Y, Moreira Mda C, Heringer-Walther S, Ebermann L, Schultheiss HP, Wessel N, Siems WE, Walther T, , 2010. Plasma ACE2 activity is an independent prognostic marker in Chagas' disease and equally potent as BNP. J Card Fail 16: 157163.[Crossref]
  28. Mahler E, Hoebeke J, Levin MJ, , 2004. Structural and functional complexity of the humoral response against the Trypanosoma cruzi ribosomal P2 beta protein in patients with chronic Chagas' heart disease. Clin Exp Immunol 136: 527534.[Crossref]
  29. Elies R, Ferrari I, Wallukat G, Lebesgue D, Chiale P, Elizari M, Rosenbaum M, Hoebeke J, Levin MJ, , 1996. Structural and functional analysis of the B cell epitopes recognized by anti-receptor autoantibodies in patients with Chagas' disease. J Immunol 157: 42034211.
  30. Kaplan D, Ferrari I, Bergami PL, Mahler E, Levitus G, Chiale P, Hoebeke J, Van Regenmortel MH, Levin MJ, , 1997. Antibodies to ribosomal P proteins of Trypanosoma cruzi in Chagas disease possess functional autoreactivity with heart tissue and differ from anti-P autoantibodies in lupus. Proc Natl Acad Sci USA 94: 1030110306.[Crossref]
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.2012.11-0533
Loading
/content/journals/10.4269/ajtmh.2012.11-0533
Loading

Data & Media loading...

  • Received : 17 Aug 2011
  • Accepted : 12 Apr 2012

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error